Overview
Evidence-based recommendations on QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography.
Last reviewed: 17 March 2021
This guidance replaces the NICE medtech innovation briefing on QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146).
Diagnostics guidance 43 has been migrated to HealthTech guidance 571.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.